Omnicell, Inc. (NASDAQ:OMCL) Stake Lifted by Nomura Holdings Inc.

Nomura Holdings Inc. raised its position in Omnicell, Inc. (NASDAQ:OMCL) by 85.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 106,463 shares of the company’s stock after acquiring an additional 48,906 shares during the quarter. Nomura Holdings Inc.’s holdings in Omnicell were worth $4,740,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in OMCL. Smartleaf Asset Management LLC lifted its stake in shares of Omnicell by 51.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 803 shares of the company’s stock worth $35,000 after acquiring an additional 273 shares during the period. Johnson Financial Group Inc. purchased a new stake in shares of Omnicell during the fourth quarter valued at $37,000. Van ECK Associates Corp lifted its stake in Omnicell by 47.0% during the fourth quarter. Van ECK Associates Corp now owns 985 shares of the company’s stock valued at $44,000 after buying an additional 315 shares in the last quarter. Headlands Technologies LLC acquired a new position in Omnicell in the 4th quarter worth approximately $53,000. Finally, First Horizon Advisors Inc. boosted its position in shares of Omnicell by 36.3% in the fourth quarter. First Horizon Advisors Inc. now owns 1,333 shares of the company’s stock worth $59,000 after buying an additional 355 shares during the period. 97.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

OMCL has been the topic of a number of research analyst reports. Wells Fargo & Company raised shares of Omnicell from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $31.00 to $35.00 in a research report on Wednesday. Benchmark decreased their target price on Omnicell from $62.00 to $40.00 and set a “buy” rating for the company in a research report on Wednesday, May 7th. JPMorgan Chase & Co. lowered their price target on Omnicell from $44.00 to $36.00 and set a “neutral” rating on the stock in a research report on Thursday, March 20th. Finally, StockNews.com cut shares of Omnicell from a “buy” rating to a “hold” rating in a research note on Saturday, May 3rd. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Omnicell currently has a consensus rating of “Hold” and a consensus target price of $46.50.

Omnicell Stock Down 2.3%

Shares of NASDAQ:OMCL opened at $28.08 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.22 and a current ratio of 1.37. Omnicell, Inc. has a 52 week low of $22.66 and a 52 week high of $55.75. The company has a 50 day moving average price of $31.57 and a two-hundred day moving average price of $39.64. The company has a market capitalization of $1.32 billion, a PE ratio of 104.00, a PEG ratio of 7.53 and a beta of 0.78.

Omnicell (NASDAQ:OMCL) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.10. The firm had revenue of $269.67 million for the quarter, compared to the consensus estimate of $260.18 million. Omnicell had a return on equity of 3.82% and a net margin of 1.13%. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the business posted $0.03 EPS. Analysts forecast that Omnicell, Inc. will post 1.09 earnings per share for the current year.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.